Vivos Inc. (OTCMKTS:RDGL) Sees Large Growth in Short Interest

Vivos Inc. (OTCMKTS:RDGL) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 93,600 shares, an increase of 1,513.8% from the February 13th total of 5,800 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 3,207,700 shares, the short-interest ratio is currently 0.0 days.

Vivos Stock Performance

RDGL stock traded up $0.00 during trading on Wednesday, hitting $0.12. 360,833 shares of the company traded hands, compared to its average volume of 1,221,905. The company has a 50-day moving average of $0.13 and a 200-day moving average of $0.13. Vivos has a 1 year low of $0.06 and a 1 year high of $0.26. The firm has a market capitalization of $52.86 million, a PE ratio of -11.65 and a beta of 0.89.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.